Inventor · Potomac, MD, US

Albert B. Deisseroth

33Patents
5h-index
12Co-inventors
66Inventor score

Filing activity: Jul 29, 1993 → Apr 22, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US5417978A Liposomal antisense methyl phosphonate oligonucleotides and methods for their preparation and use Chemistry; Metallurgy 123 Expired
US8119117B2 Adenoviral expression vector comprising a CD40L fusion protein adapted to elicit cellular immunity Chemistry; Metallurgy 23 Active
US8828957B2 Methods for generating immunity to antigen Chemistry; Metallurgy 6 Active
US8299229B2 Mucin antigen vaccine Chemistry; Metallurgy 6 Expired
US8236295B1 Composition comprising an adenoviral expression vector comprising a CD40L fusion protein for generating immune responses Chemistry; Metallurgy 5 Active
US8501707B2 Mucin antigen vaccine Chemistry; Metallurgy 4 Active
US9533036B2 Methods for generating immune responses to influenza antigens with a secretable CD40L fusion protein Chemistry; Metallurgy 4 Active
US10046041B2 Methods and compositions for suppressing virulence of methicillin resistant Staphylococcus aureus Chemistry; Metallurgy 2 Active
US8540979B2 Methods of generating immune responses with compositions comprising an adenoviral expression vector comprising a CD40L fusion protein Chemistry; Metallurgy 2 Active
US8742087B2 Mucin antigen vaccine Chemistry; Metallurgy 2 Active
US9353167B2 Methods for generating immunity to antigen Chemistry; Metallurgy 2 Active
US10383932B2 Vaccine directed to induction of immune response to protein and glycolipid antigens of bacterial cells through interaction of CD4OL/CD40 receptor axis with complex of glycolipid/CD1d receptor in NKT cells and in dendritic cells Chemistry; Metallurgy 1 Active
US7304092B1 Compounds and methods for treating tumors, cancer and hyperproliferative diseases Chemistry; Metallurgy 1 Expired
US9526774B1 Methods and compositions for suppressing virulence of methicillin resistant Staphylococcus aureus Chemistry; Metallurgy 1 Active
US9458221B2 Adenoviral expression vector encoding a CD40L fusion protein Chemistry; Metallurgy 1 Active
US9402920B2 Mucin antigen vaccine Chemistry; Metallurgy 1 Active
US9642901B1 TAA/CD40L vaccine for malaria Emerging Cross-Sectional Technologies 1 Active
US9757438B2 Mucin antigen vaccine Chemistry; Metallurgy 1 Active
US10149899B1 Composition and method against C-difficile Chemistry; Metallurgy 0 Active
US12427191B1 SARS-CoV-2 fusion protein vaccine/regimen Chemistry; Metallurgy 0 Active
US10835589B2 Vaccine directed to induction of immune response to protein and glycolipid antigens of bacterial cells through interaction of CD40L/CD40 receptor axis with complex of glycolipid/CD1d receptor in NKT cells and in dendritic cells Chemistry; Metallurgy 0 Active
US10130667B1 TAA/ecdCD40L oncolytic virus Chemistry; Metallurgy 0 Active
US10166284B1 Vaccines for herpes simplex virus 1 and 2 Chemistry; Metallurgy 0 Active
US10293040B1 Pharmaceutical compositions and methods of blocking Bacillus anthracis Chemistry; Metallurgy 0 Active
US11077183B2 CD40 ligand fusion protein vaccine Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.